Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew A Li

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Diseases (Basel, Switzerland)|September 12, 2018
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLDBrandon J Perumpail, Andrew A Li, Umair Iqbal, et al.
Journal of Viral Hepatitis|August 17, 2018
Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016Andrew A Li, Donghee Kim, Won Kim, et al.
Diseases (Basel, Switzerland)|March 3, 2019
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLDBrandon J Perumpail, Andrew A Li, Nimy John, et al.
Transplantation|October 10, 2018
Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United StatesGeorge Cholankeril, Chiranjeevi Gadiparthi, Eric R Yoo, et al.
Diseases (Basel, Switzerland)|September 26, 2018
The Role of Vitamin E in the Treatment of NAFLDBrandon J Perumpail, Andrew A Li, Nimy John, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2017
Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral AgentsGeorge Cholankeril, Andrew A Li, Katherine L March, et al.
Gut and Liver|March 9, 2025
Pyloric Dysfunction: A Review of the Mechanisms, Diagnosis, and TreatmentHee Kyong Na, Andrew A Li, Andres Gottfried-Blackmore, et al.
Diseases (Basel, Switzerland)|September 22, 2018
Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLDPratima Dibba, Andrew A Li, Brandon J Perumpail, et al.
Gastroenterology|June 29, 2019
Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017Donghee Kim, Adeyinka C Adejumo, Eric R Yoo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 26, 2023
Protein Corona Sensor Array Nanosystem for Detection of Coronary Artery DiseaseGha Young Lee, Andrew A Li, Intae Moon, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Diseases (Basel, Switzerland)|September 12, 2018
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLDBrandon J Perumpail, Andrew A Li, Umair Iqbal, et al.
Journal of Viral Hepatitis|August 17, 2018
Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016Andrew A Li, Donghee Kim, Won Kim, et al.
Diseases (Basel, Switzerland)|March 3, 2019
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLDBrandon J Perumpail, Andrew A Li, Nimy John, et al.
Transplantation|October 10, 2018
Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United StatesGeorge Cholankeril, Chiranjeevi Gadiparthi, Eric R Yoo, et al.
Diseases (Basel, Switzerland)|September 26, 2018
The Role of Vitamin E in the Treatment of NAFLDBrandon J Perumpail, Andrew A Li, Nimy John, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2017
Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral AgentsGeorge Cholankeril, Andrew A Li, Katherine L March, et al.
Gut and Liver|March 9, 2025
Pyloric Dysfunction: A Review of the Mechanisms, Diagnosis, and TreatmentHee Kyong Na, Andrew A Li, Andres Gottfried-Blackmore, et al.
Diseases (Basel, Switzerland)|September 22, 2018
Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLDPratima Dibba, Andrew A Li, Brandon J Perumpail, et al.
Gastroenterology|June 29, 2019
Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017Donghee Kim, Adeyinka C Adejumo, Eric R Yoo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 26, 2023
Protein Corona Sensor Array Nanosystem for Detection of Coronary Artery DiseaseGha Young Lee, Andrew A Li, Intae Moon, et al.
Pageof 6